Black Seed Oil Nano-Delivery Systems for Fighting Staph Infections

Greg Howard
21st July, 2024

Black Seed Oil Nano-Delivery Systems for Fighting Staph Infections

Nigella (Nigella sativa)

Photo adapted from: Patrick Hacker / CC BY (Source)

Key Findings

  • Researchers at Guilan University of Medical Sciences studied Nigella Sativa oil (NSO) encapsulated in nanocarriers to fight antibiotic-resistant Staphylococcus aureus
  • NSO encapsulated in chitosan nanoparticles (NS-CH) showed the strongest antibacterial effect, with a Minimum Inhibitory Concentration (MIC) of 80 µg/mL
  • The study suggests that using nanotechnology to deliver NSO could be a promising alternative to traditional antibiotics for treating drug-resistant infections
Staphylococcus aureus is a significant global health concern due to its ability to develop resistance to various antibiotics. This resistance complicates treatment and increases morbidity, mortality, and healthcare costs. Researchers at Guilan University of Medical Sciences have investigated the potential of Nigella Sativa oil (NSO) encapsulated in nanocarriers to enhance its antibacterial effects against S. aureus[1]. S. aureus is known for causing various infections, including hospital-acquired and community-acquired infections, and has shown a remarkable ability to develop resistance to multiple drugs[2]. Traditional antibiotics often fail to combat these resistant strains, necessitating the exploration of alternative therapeutic strategies. Nigella Sativa, a plant known for its medicinal properties, has shown promise as an antimicrobial agent. Previous studies have demonstrated its efficacy against various pathogens, including antibiotic-resistant Salmonella enterica[3]. In this recent study, researchers explored the use of nanotechnology to enhance the antibacterial effectiveness of NSO. They hypothesized that incorporating NSO into nanocarriers, specifically NS-SLN (solid lipid nanoparticles) and NS-CH (chitosan nanoparticles), would improve its ability to inhibit S. aureus. The study evaluated the physicochemical properties and antibacterial characteristics of these nanocarriers. Transmission Electron Microscopy (TEM) images revealed that both NS-SLN and NS-CH nanoparticles had a round shape with clear edges. The average sizes of the nanoparticles were 196.4 nm for NS-SLN and 446.6 nm for NS-CH. The zeta potential, which indicates the stability of the nanoparticles in suspension, was -28.9 mV for NS-SLN and 59.4 mV for NS-CH. Encapsulation efficiency, a measure of how much NSO was successfully incorporated into the nanoparticles, was 73.22% for NS-SLN and 88% for NS-CH. The Minimum Inhibitory Concentrations (MICs) of NSO, NS-SLN, and NS-CH against S. aureus were determined to be 480 µg/mL, 200 µg/mL, and 80 µg/mL, respectively. These results indicate that NSO encapsulated in chitosan nanoparticles (NS-CH) had the strongest antibacterial effect, followed by NSO in solid lipid nanoparticles (NS-SLN), and then NSO alone. The significantly lower MIC for NS-CH suggests that chitosan nanoparticles are particularly effective in enhancing the antibacterial properties of NSO. This study builds on previous research that highlighted the potential of nanomaterials to combat multidrug-resistant bacteria[2]. By demonstrating the enhanced antibacterial effects of NSO when delivered via nanocarriers, this research provides a promising alternative to traditional antibiotics. The use of nanotechnology to improve the delivery and efficacy of antimicrobial agents could be a crucial step in addressing the growing problem of antibiotic resistance. Moreover, the findings align with earlier studies that explored the use of phytochemicals and nanomaterials to combat antibiotic-resistant pathogens[3]. The incorporation of NSO into chitosan nanoparticles not only enhances its antibacterial properties but also offers a potential solution for treating infections caused by drug-resistant S. aureus. This approach could be particularly beneficial for high-risk individuals, such as those with cystic fibrosis or severe burns, who are more susceptible to infections by antibiotic-resistant bacteria[4]. In conclusion, the study conducted by Guilan University of Medical Sciences demonstrates the potential of NSO-loaded chitosan nanoparticles as an effective antimicrobial agent against S. aureus. By leveraging the advantages of nanotechnology, this approach could offer a viable alternative to conventional antibiotics, addressing the urgent need for new strategies to combat antibiotic-resistant bacteria.

MedicineBiotechBiochem

References

Main Study

1) SLN and chitosan nano-delivery systems for antibacterial effect of black seed (Nigella sativa) oil against S. aureus.

Published 21st July, 2024

https://doi.org/10.1080/09603123.2024.2378103

Related Studies

2) Regulation of Staphylococcus aureus Virulence and Application of Nanotherapeutics to Eradicate S. aureus Infection.

https://doi.org/10.3390/pharmaceutics15020310

3) In vitro activity of Nigella sativa against antibiotic resistant Salmonella enterica.

https://doi.org/10.1016/j.etap.2017.12.017

4) Phage Therapy as an Alternative Treatment Modality for Resistant Staphylococcus aureus Infections.

https://doi.org/10.3390/antibiotics12020286


Related Articles

An unhandled error has occurred. Reload 🗙